Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000628047 | SCV000748935 | pathogenic | Ataxia-telangiectasia syndrome | 2023-08-30 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Asn2742Hisfs*4) in the ATM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). This variant is present in population databases (no rsID available, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with ATM-related conditions. ClinVar contains an entry for this variant (Variation ID: 524334). For these reasons, this variant has been classified as Pathogenic. |
Ambry Genetics | RCV001027302 | SCV001189837 | pathogenic | Hereditary cancer-predisposing syndrome | 2018-09-17 | criteria provided, single submitter | clinical testing | The c.8224_8225delAA pathogenic mutation, located in coding exon 55 of the ATM gene, results from a deletion of two nucleotides at nucleotide positions 8224 to 8225, causing a translational frameshift with a predicted alternate stop codon (p.N2742Hfs*4). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Baylor Genetics | RCV003465373 | SCV004212256 | likely pathogenic | Familial cancer of breast | 2022-06-18 | criteria provided, single submitter | clinical testing |